Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"
18/10/24 Rigla OOO and Public Joint-Stock Company PROTEK acquired Prime-Pharm LLC, Apteka 52 LLC, First Pharmacy LLC, Solo-Pharm LLC, Nizhegorodskaya Pharmacy LLC network, LLC ? First Pharmacy, LLC ?Pharmacy 24, LLC, Vita+, LLC, Pharmacy 78, LLC and Premier-pharm?, LLC from Yuri Gaysinsky. CI
30/04/20 Public Joint-Stock Company Protek Reports Earnings Results for the Full Year Ended December 31, 2019 CI
28/08/18 Protek Group Reports Consolidated Earnings Results for the First Half of 2018 CI
04/12/17 JSC Rafarma announced that it has received funding from Public Joint-Stock Company PROTEK CI
27/11/17 Protek OOO acquired an additional 0.19% stake in Public Joint-Stock Company PROTEK. CI
23/11/17 Protek LLC acquired an additional 0.0522% stake in Public Joint-Stock Company PROTEK. CI
26/10/17 PROTEK Group Announces Unaudited Consolidated Revenue Results for Third Quarter and Nine Months Ended September 30, 2017 CI
25/08/17 The Protek Reports Consolidated Earnings Results for the First Half of Fiscal Year 2017 CI
20/04/17 PROTEK Group Reports Audited Consolidated Earnings Results for the Year 2016 CI
18/04/17 Open Joint Stock Company Protek completed the acquisition of Joint Stock Company Rafarma from Rafarma Pharmaceuticals, Inc.. CI
09/02/17 PROTEK Group Reports Preliminary Consolidated Unaudited Revenue Results for Fourth Quarter and Full Year 2016 CI
23/12/16 Open Joint Stock Company Protek sold 51% stake in Firma Koman Zao. CI
16/11/16 Ortes ZAO acquired LLC Protek Finance from Public Joint-Stock Company PROTEK. CI
Manager TitleAgeSince
Director of Finance/CFO - -
Chief Executive Officer 68 01/10/2014
Corporate Officer/Principal 69 01/01/2003
Director TitleAgeSince
Director/Board Member 69 01/01/2002
Chairman 63 01/01/2002
Director/Board Member 63 01/10/2011
Change 5-day change 1-year change 3-year change Capi.($)
-.--%+0.10% - - 601M
+0.91%-3.52%-12.83%-8.25% 5.54B
-0.26%+6.47%-2.48%+50.14% 3.5B
+0.49%-3.04%-34.07%-15.33% 2.91B
+1.37%-1.21%-14.67%-11.91% 2.69B
-2.35%-6.02%+0.37%+30.43% 2.15B
+1.11%-2.55%-44.40%-49.16% 1.32B
+0.77%-0.15%+2.36%-7.79% 1.29B
-3.85%-3.85%0.00%+201.20% 590M
+3.43%+2.70%+30.83%+66.67% 484M
Average +0.16%-1.09%-8.32%+28.44% 2.27B
Weighted average by Cap. +0.29%-1.38%-12.61%+9.51%
Logo PROTEK
Protek PAO is a Russia-based vertically integrated pharmaceutical holding company. Together with its subsidiaries, the Company forms Protek Group, which is engaged in various segments of the pharmaceutical industry. The Company focuses on such business segments as: Distribution, Retail and Production. The Company has three plants involved in the pharmaceuticals, beauty and health products manufacture: FarmFirma Soteks ZAO, Protek-SVM OOO and Proteinovyi Kontur OOO. The Company operates through numerous subsidiaries and affiliated companies, located domestically and in Ukraine, the Virgin Islands and Cyprus.
Employees
-
  1. Stock Market
  2. Stocks
  3. PRTK Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!